Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

Loop connected on all three of his field-goal attempts and made both of his point-after tries during the Ravens' 23-10 win over the Jets on Sunday. Loop gave the Ravens their first points of the game ...

Marissa Sulek joined CBS News Chicago in January 2025. Before Chicago, Marissa was a general assignment reporter in Nashville at WSMV, where she was nominated for Mid-South Emmy Awards for her ...

Researchers at Google have developed a new AI paradigm aimed at solving one of the biggest limitations in today’s large language models: their inability to learn or update their knowledge after ...

Recursion Pharmaceuticals, Inc. leverages AI to accelerate drug discovery, offering both a licensing platform and an internal drug development pipeline. RXRX faces heavy competition, ongoing operating ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

All products featured here are independently selected by our editors and writers. If you buy something through links on our site, Gizmodo may earn an affiliate commission. Reading time 7 minutes ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...

Management believes it can drastically cut down the time and cost to bring drugs to market. The company is involved with multiple clinical trials, but none of them are in late stages just yet. Its ...